- Report
- December 2023
- 255 Pages
Global
From €1099EUR$1,250USD£950GBP
€2197EUR$2,500USD£1,901GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- December 2023
- 80 Pages
China
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- December 2023
- 80 Pages
France
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- December 2023
- 80 Pages
Germany
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- December 2023
- 80 Pages
South Korea
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- December 2023
- 80 Pages
United States
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- October 2023
- 185 Pages
Global
€4215EUR$4,795USD£3,646GBP
- Report
- August 2024
- 74 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- December 2023
- 100 Pages
Africa
From €879EUR$1,000USD£760GBP
€1758EUR$2,000USD£1,521GBP
- Report
- December 2023
- 80 Pages
Russia
From €659EUR$750USD£570GBP
€1318EUR$1,500USD£1,140GBP
- Report
- September 2025
- 50 Pages
Global
From €2329EUR$2,650USD£2,015GBP
- Report
- January 2025
- 132 Pages
Global
From €835EUR$950USD£722GBP

Chloroquine is an antimalarial drug used to treat and prevent infectious diseases caused by certain parasites. It is also used to treat rheumatoid arthritis, lupus, and porphyria cutanea tarda. Chloroquine is a widely used drug in the treatment of infectious diseases, particularly malaria. It is also used to treat other diseases such as amebiasis, rheumatoid arthritis, and lupus. Chloroquine is a safe and effective drug with a long history of use in the treatment of infectious diseases. It is generally well tolerated and has few side effects. Chloroquine is available in both oral and injectable forms.
Companies in the Chloroquine market include Bayer, Sanofi, GlaxoSmithKline, Merck, Pfizer, Novartis, and Teva Pharmaceuticals. Show Less Read more